Module

Management of Hepatitis B: Understanding Treatment Candidacy and Factors for Selecting Initial Therapy

Source: Choosing First-Line Therapy in Chronic Hepatitis B

Management of Hepatitis B: Understanding Treatment Candidacy and Factors for Selecting Initial Therapy

Faculty:

Kris V. Kowdley, MD, FACP

CME CREDIT INFORMATION

Release Date: 07/12/07

Expiration Date: 07/11/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the goals of hepatitis B virus (HBV) therapy in hepatitis B e antigen (HBeAg)–negative and HBeAg-positive hepatitis B patients
Summarize the efficacy data for currently available HBV therapies
Discuss the factors for selecting optimal first-line therapy in hepatitis B patients

Topics covered include:

Introduction
When to Initiate Therapy
Key Factors for Selecting First-line Treatment
Additional Factors for Selecting First-Line Treatment
Summary

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.